Lactobacillus reuteri protects epidermal keratinocytes from Staphylococcus aureus-induced cell death by competitive exclusion

Applied and Environmental Microbiology

Volumn 78, Issue 15, 2012, Pages 5119-5126

  Prince, Tessa ^a   McBain, Andrew J ^a   O'Neill, Catherine A ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

INTEGRINS; KERATINOCYTE CULTURES; KERATINOCYTES; LACTOBACILLUS REUTERI; LACTOBACILLUS RHAMNOSUS; PROBIOTIC BACTERIA; PROBIOTICS; PROTECTIVE EFFECTS; S. AUREUS; STAPHYLOCOCCUS AUREUS; TOPICAL APPLICATION;

BACILLI; CELL CULTURE; LACTIC ACID;

CELL DEATH;

PROBIOTIC AGENT;

BACTERIUM; COLONIZATION; DISEASE PREVALENCE; HOST-PATHOGEN INTERACTION; INHIBITION; INHIBITOR; NUMERICAL MODEL;

ANALYSIS OF VARIANCE; APOPTOSIS; ARTICLE; CELL ADHESION; CELL CULTURE; DRUG EFFECT; HUMAN; KERATINOCYTE; LACTOBACILLUS REUTERI; MICROBIOLOGY; ORGANISMAL INTERACTION; PATHOGENICITY; PHYSIOLOGY; SPECIES DIFFERENCE; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS INFECTION;

ANALYSIS OF VARIANCE; APOPTOSIS; CELL ADHESION; CELLS, CULTURED; HUMANS; KERATINOCYTES; LACTOBACILLUS REUTERI; MICROBIAL INTERACTIONS; PROBIOTICS; SPECIES SPECIFICITY; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS;

LACTOBACILLUS REUTERI; LACTOBACILLUS RHAMNOSUS; LACTOBACILLUS SALIVARIUS; STAPHYLOCOCCUS AUREUS;

EID: 84866170776     PISSN: 00992240     EISSN: 10985336     Source Type: Journal    
DOI: 10.1128/AEM.00595-12     Document Type: Article

References (47)

1. Aly R, Shinefield HR, Litz C, Maibach HI. 1980. Role of teichoic acid in the binding of Staphylococcus aureus to nasal epithelial cells. J. Infect. Dis. 141:463-465.
2. Bäckhed F, Ley RE, Sonnenburg JL, Peterson DA, Gordon JI. 2005. Host-bacterial mutualism in the human intestine. Science 307:1915-1920.
3. Balma-Mena A, et al. 2011. Colonization with community-acquired methicillin- resistant Staphylococcus aureus in children with atopic dermatitis: a cross-sectional study. Int. J. Dermatol. 50:682-688.
4. Banerjee P, Merkel G, Bhunia A. 2009. Lactobacillus delbrueckii ssp.bulgaricus B-30892 can inhibit cytotoxic effects and adhesion of pathogenic Clostridium difficile to Caco-2 cells. Gut Pathog. 1:8.
5. Bek-Thomsen M, Lomholt HB, Kilian M. 2008. Acne is not associated with yet-uncultured bacteria. J. Clin. Microbiol. 46:3355-3360.
6. Bowler PG, Duerden BI, Armstrong DG. 2001. Wound microbiology and associated approaches to wound management. Clin. Microbiol. Rev. 14:244-269.
7. Burkhart CN, Burkhart CG. 2003. Microbiology's principle of biofilms as a major factor in the pathogenesis of acne vulgaris. Int. J. Dermatol. 42: 925-927.
8. Çaglar E, Kavaloglu Cildir Ergeneli S, Sandalli S, Twetman NS. 2006. Salivary mutans streptococci and lactobacilli levels after ingestion of the probiotic bacterium Lactobacillus reuteri ATCC 55730 by straws or tablets. Acta Odontol. Scand. 64:314-318.
9. Chen X, et al. 2007. The S-layer proteins of Lactobacillus crispatus strain ZJ001 is responsible for competitive exclusion against Escherichia coli O157:H7 and Salmonella typhimurium. Int. J. Food Microbiol. 115:307-312.
10. Coconnier MH, et al. 1993. Inhibition of adhesion of enteroinvasive pathogens to human intestinal Caco-2 cells by Lactobacillus acidophilus strain LB decreases bacterial invasion. FEMS Microbiol. Lett. 110:299-306.
11. Cotter PD, Hill C, Ross RP. 2005. Bacteriocins: developing innate immunity for food. Nat. Rev. Microbiol. 3:777-788.
12. Deepika G, Charalampopoulos D, Allen IL, Sima S, Geoffrey MG. 2010. Surface and adhesion properties of lactobacilli. Adv. Appl. Microbiol. 70: 127-152.
13. Di Marzio L, Cinque B, De Simone C, Cifone MG. 1999. Effect of the lactic acid bacterium Streptococcus thermophilus on ceramide levels in human keratinocytes in vitro and stratum corneum in vivo. J. Invest. Dermatol 113:98-106.
14. Edmond MB, et al. 1999. Nosocomial bloodstream infections in United States hospitals: a three-year analysis. Clin. Infect. Dis. 29:239-244.
15. FAO/WHO. 2002. Guidelines for the evaluation of probiotics in food: report of a joint FAO/WHO working group on drafting guidelines for the evaluation of probiotics in food. http://www.who.int/foodsafety/fs_management/en/probiotic_guidelines.pdf.
16. Gan B, Kim J, Reid G, Cadieux P, Howard J. 2002. Lactobacillus fermentum RC-14 inhibits Staphylococcus aureus infection of surgical implants in rats. J. Infect. Dis. 185:1369-1372.
17. Granato D, et al. 1999. Cell surface-associated lipoteichoic acid acts as an adhesion factor for attachment of Lactobacillus johnsonii La1 to human enterocyte-like caco-2 cells. Appl. Environ. Microbiol. 65:1071-1077.
18. Guéniche A, et al. 2010. Bifidobacterium longum lysate, a new ingredient for reactive skin. Exp. Dermatol. 19:e1-e8. doi:10.1111/j.1600-0625.2009.00932.x.
19. Heinemann C, et al. 2000. Purification and characterization of a surfacebinding protein from Lactobacillus fermentum RC-14 that inhibits adhesion of Enterococcus faecalis 1131. FEMS Microbiol. Lett. 190:177-180.
20. Helgeland L, Vaage JT, Rolstad B, Midtvedt T, Brandtzaeg P. 1996. Microbial colonization influences composition and T-cell receptor V beta repertoire of intraepithelial lymphocytes in rat intestine. Immunology 89: 494-501.
21. Holder IA, Boyce ST. 1994. Agar well diffusion assay testing of bacterial susceptibility to various antimicrobials in concentrations non-toxic for human cells in culture. Burns 20:426-429.
22. Iwase T, et al. 2010. Staphylococcus epidermidis Esp inhibits Staphylococcus aureus biofilm formation and nasal colonization. Nature 465: 346-349.
23. Karska-Wysocki B, Bazo M, Smoragiewicz W. 2010. Antibacterial activity of Lactobacillus acidophilus and Lactobacillus casei against methicillin- resistant Staphylococcus aureus (MRSA). Microbiol. Res. 165: 674-686.
24. Kintarak S, Nair SP, Speight PM, Whawell SA. 2004. A recombinant fragment of the fibronectin-binding protein of Staphylococcus aureus inhibits keratinocyte migration. Arch. Dermatol. Res. 296:250-257.
25. Kintarak S, Whawell SA, Speight PM, Packer S, Nair SP. 2004. Internalization of Staphylococcus aureus by human keratinocytes. Infect. Immun. 72:5668-5675.
26. Kluytmans J, Van Belkum A, Verbrugh H. 1997. Nasal carriage of Staphylococcus aureus: epidemiology, underlying mechanisms, and associated risks. Clin. Microbiol. Rev. 10:505-520.
27. Krut O, Utermohlen O, Schlossherr X, Krönke M. 2003. Strain-specific association of cytotoxic activity and virulence of clinical Staphylococcus aureus isolates. Infect. Immun. 71:2716-2723.
28. Lai Y, et al. 2010. Activation of TLR2 by a small molecule produced by Staphylococcus epidermidis increases antimicrobial defense against bacterial skin infections. J. Invest. Dermatol. 130:2211-2221.
29. Lai Y, et al. 2009. Commensal bacteria regulate Toll-like receptor 3-dependent inflammation after skin injury. Nat. Med. 15:1377-1382.
30. Lee YK, Puong KY, Ouwehand AC, Salminen S. 2003. Displacement of bacterial pathogens from mucus and caco-2 cell surface by lactobacilli. J. Med. Microbiol. 52:925-930.
31. Mack DR, Michail S, Wei S, Mcdougall L, Hollingsworth MA. 1999. Probiotics inhibit enteropathogenic E. coli adherence in vitro by inducing intestinal mucin gene expression. Am. J. Physiol. Gastrointest. Liver Physiol. 276:G941-G950.
32. Maudsdotter L, Jonsson H, Roos S, Jonsson A-B. 2011. Lactobacilli reduce cell cytotoxicity caused by Streptococcus pyogenes by producing lactic acid that degrades the toxic component lipoteichoic acid. Antimicrob.Agents Chemother. 55:1622-1688.
33. Mempel M, et al. 1998. Role of Staphylococcus aureus surface-associated proteins in the attachment to cultured HaCaT keratinocytes in a new adhesion assay. J. Invest. Dermatol. 111:452-456.
34. Mempel M, et al. 2002. Invasion of human keratinocytes by Staphylococcus aureus and intracellular bacterial persistence represent haemolysin- independent virulence mechanisms that are followed by features of necrotic and apoptotic keratinocyte cell death. Br. J. Dermatol.146:943-951.
35. Miyoshi Y, Okada S, Uchimura T, Satoh E. 2006. A mucus adhesion promoting protein, MapA, mediates the adhesion of Lactobacillus reuteri to caco-2 human intestinal epithelial cells. Biosci. Biotechnol. Biochem.70:1622-1628.
36. Nikawa H, et al. 2004. Lactobacillus reuteri in bovine milk fermented decreases the oral carriage of mutans streptococci. Int. J. Food Microbiol.95:219-223.
37. Ouwehand AC, Isolauri E, Kirjavainen PV, Tölkkö S, Salminen SJ. 2000. The mucus binding of Bifidobacterium lactis Bb12 is enhanced in the presence of Lactobacillus GG and Lactobacillus delbrueckii subsp. bulgaricus.Lett. Appl. Microbiol. 30:10-13.
38. Peral MC, Huaman Martinez MA, Valdez JC. 2009. Bacteriotherapy with Lactobacillus plantarum in burns. Int. Wound J. 6:73-81.
39. Peral MC, Rachid MM, Gobbato NM, Martinez MAH, Valdez JC. 2010. Interleukin-8 production by polymorphonuclear leukocytes from patients with chronic infected leg ulcers treated with Lactobacillus plantarum. Clin. Microbiol. Infect. 16:281-286.
40. Rembacken BJ, Snelling AM, Hawkey PM, Chalmers DM, Axon ATR. 1999. Non-pathogenic Escherichia coli versus mesalazine for the treatment of ulcerative colitis: a randomised trial. Lancet 354:635-639.
41. Ron EZ, Rosenberg E. 2001. Natural roles of biosurfactants. Environ. Microbiol. 3:229-236.
42. Shornikova AV, Casas IA, Isolauri E, Mykkanen H, Vesikari T. 1997. Lactobacillus reuteri as a therapeutic agent in acute diarrhea in young children. J. Pediatr. Gastroenterol. Nutr. 24:399-404.
43. Strober W. 1997. Trypan blue exclusion test of cell viability. Curr. Protoc. Immunol. May:Appendix 3B. doi:10.1002/0471142735.ima03bs21.
44. Valdéz JC, Peral MC, Rachid M, Santana M, Perdigón G. 2005. Interference of Lactobacillus plantarum with Pseudomonas aeruginosa in vitro and in infected burns: the potential use of probiotics in wound treatment. Clin. Microbiol. Infect. 11:472-479.
45. Vanderhoof JA, et al. 1999. Lactobacillus GG in the prevention of antibiotic- associated diarrhea in children. J. Pediatr. 135:564-568.
46. Wanke I, et al. 2011. Skin commensals amplify the innate immune response to pathogens by activation of distinct signaling pathways. J. Invest. Dermatol. 131:382-390.
47. Zarate G, Nader-Macias ME. 2006. Influence of probiotic vaginal lactobacilli on in vitro adhesion of urogenital pathogens to vaginal epithelial cells. Lett. Appl. Microbiol. 43:174-180.